GSA Capital Partners’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Buy |
+44,690
| New | +$103K | 0.01% | 1612 |
|
|
2024
Q4 | – | Sell |
-233,560
| Closed | -$469K | – | 2040 |
|
|
2024
Q3 | $469K | Buy |
233,560
+91,755
| +65% | +$184K | 0.04% | 946 |
|
|
2024
Q2 | $318K | Buy |
+141,805
| New | +$318K | 0.02% | 1247 |
|
|
2023
Q3 | – | Sell |
-18,077
| Closed | -$12K | – | 1916 |
|
|
2023
Q2 | $12K | Sell |
18,077
-9,261
| -34% | -$6.15K | ﹤0.01% | 1453 |
|
|
2023
Q1 | $22K | Sell |
27,338
-156,519
| -85% | -$126K | ﹤0.01% | 1425 |
|
|
2022
Q4 | $416K | Sell |
183,857
-52,263
| -22% | -$118K | 0.05% | 714 |
|
|
2022
Q3 | $456K | Buy |
236,120
+49,640
| +27% | +$95.9K | 0.06% | 642 |
|
|
2022
Q2 | $694K | Buy |
186,480
+69,371
| +59% | +$258K | 0.1% | 310 |
|
|
2022
Q1 | $764K | Buy |
117,109
+76,224
| +186% | +$497K | 0.1% | 297 |
|
|
2021
Q4 | $476K | Buy |
+40,885
| New | +$476K | 0.06% | 635 |
|
|
2020
Q4 | – | Sell |
-20,000
| Closed | -$448K | – | 1600 |
|
|
2020
Q3 | $448K | Buy |
+20,000
| New | +$448K | 0.07% | 464 |
|